Etanercept and infliximab associated with cutaneous vasculitis

Rheumatology (Oxford). 2002 Jan;41(1):116-7. doi: 10.1093/rheumatology/41.1.116.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Arthritis, Rheumatoid / diagnosis*
  • Arthritis, Rheumatoid / drug therapy*
  • Drug Interactions
  • Drug Therapy, Combination
  • Etanercept
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoglobulin G / adverse effects*
  • Immunoglobulin G / therapeutic use
  • Infliximab
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Risk Assessment
  • Severity of Illness Index
  • Vasculitis / chemically induced*
  • Vasculitis / diagnosis

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Infliximab
  • Etanercept